Ganoderma lucidum polysaccharides peptide (GLPP) protects ECV304 cells from oxidative injury

Chinese Pharmacological Bulletin

Volumn 23, Issue 11, 2007, Pages

  You, Yu Hong ^a   Lin, Zhi Bin ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apoptosis; ECV304; Flow cytometry; Ganoderma lucidum polysaccharides peptide; Mitochondria; Oxidative injury

Indexed keywords

GANODERMA LUCIDUM EXTRACT; LIPOCORTIN 5; OXYGEN RADICAL; POLYSACCHARIDE PEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL SURVIVAL; DRUG MECHANISM; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GANODERMA LUCIDUM; SURVIVAL RATE;

EID: 38349161133     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lin Z B, editor. Modern research of Ganodernm[M]. 2nd ed, Beijing: Beijing Medical University Publishing House,2001:284-304.
2. Lei L S, Lin Z B. Effects of Ganoderma polysaccharides on the activity of DNA polymerase α in spleenocytes and immune function in aged mice[J]. Acta Pharm Sin,1993,28:577-82.
3. Zhang Q H, Lin Z B. Study on antitumor activity and mechanism of Ganoderma polysaccharides B[J]. Chin J Integr Trad West Med,1999, 19:544-7.
4. Gui X F, Wang L, Yang Y H, et al. The study of protecting kidney cortical from radicals with the use of ganoderma lucidum injection[J]. Chin J Biochem Pharm,1996,17:188 -90.
5. You Y H, Lin Z B. Antioxidation effects of ganoderma lucidum[J]. Acta Pharm Sin,2003,38:81-4.
6. You Y H, Lin Z B. The effects of ganoderma lucidum polysaccharides peptide (GLPP) on the nitric oxide production in mice peritoneal macrophages[J]. Chin Pharm Bull,2004,12:1398-400.
7. You Y H, Lin Z B. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species[J]. Acta Pharmacol Sin,2002,23:787-91.
8. You Y H, Lin Z B. The free radical scavenging activity by ganoderma lucidum polysaccharides peptide (GLPP) in mice peritoneal macrophages[J]. Chin J Pharmacol Ther,2004,1:52-5.
9. Zhang J T, editor. Modern expenmental method in pharmacology [M]. Beijing: Beijing University and Peking Union Medical College Publishing House,1998:2121-38.
10. Li H, Yin H C, Zhang H, et al. Activation of NF-κB and its effect on induction of platelet-derived growth factor-B transcription by angiotensin II in ECV304 cell line[J]. Chin J Pathol,2001,30(4):276-80.
11. Wang H, Si Q, Wang X M, et al. Effects of angiotensin II on the three transcription factor in endothelial cells[J]. Chin J Pathophysiol,2001, 17(3):196-9.
12. Gao J, Xue A N. Study on the oxidative injury of ECV304 cell induced by homocysteine[J]. J Hygiene Res,2003,32(1):20-1.
13. Wu Q X, Qiu J. ECV304 cells can be used as a general model, tool or target in the research of biomedicine and pharmacology[J]. Chin J Pathophysiol,2004,20(1):139-42.
14. Ma L, Kou J P, Huang Y, et al. Effects of ruscogenin on adhesion of HL-60 cells to ECV304 cells[J]. Chin Pharmacol Bull,2006,22(6):706-9.